
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $932.7M | -- | -- | $1.92 | -- |
07/24/2025 | Q2 | $959.7M | -- | -- | $2.06 | -- |
04/24/2025 | Q1 | $911M | $934M | $2.36 | $1.86 | $0.50 |
02/18/2025 | Q4 | $954.2M | $939M | $4.37 | $1.97 | $2.40 |
10/24/2024 | Q3 | $977.4M | $980M | $1.40 | $1.83 | -$0.43 |
07/25/2024 | Q2 | $1B | $1B | $2.54 | $1.96 | $0.58 |
04/25/2024 | Q1 | $974M | $933M | $1.50 | $1.68 | -$0.18 |
02/20/2024 | Q4 | $1B | $990M | $12.85 | $2.09 | $10.76 |
10/26/2023 | Q3 | -- | -- | $2.32 | $1.98 | $0.34 |
08/03/2023 | Q2 | -- | -- | $0.70 | $1.60 | -$0.90 |
04/27/2023 | Q1 | -- | -- | $1.18 | $1.20 | -$0.02 |
02/16/2023 | Q4 | -- | -- | $1.18 | $1.49 | -$0.31 |
10/27/2022 | Q3 | -- | -- | $1.54 | $1.24 | $0.30 |
07/28/2022 | Q2 | -- | -- | $0.85 | $0.48 | $0.37 |
04/28/2022 | Q1 | -- | -- | $0.77 | $0.62 | $0.15 |
02/17/2022 | Q4 | -- | -- | $1.09 | $0.08 | $1.01 |
10/28/2021 | Q3 | -- | -- | $0.18 | $0.15 | $0.03 |
07/29/2021 | Q2 | -- | -- | -$0.39 | $0.04 | -$0.43 |
04/29/2021 | Q1 | -- | -- | $0.56 | $0.26 | $0.30 |
02/18/2021 | Q4 | -- | -- | $0.64 | $1.19 | -$0.55 |
10/29/2020 | Q3 | -- | -- | $0.21 | $0.54 | -$0.33 |
07/30/2020 | Q2 | -- | -- | -$1.62 | -$2.08 | $0.46 |
04/30/2020 | Q1 | -- | -- | -$1.25 | -$0.51 | -$0.74 |
02/20/2020 | Q4 | -- | -- | $1.24 | $1.57 | -$0.33 |
10/24/2019 | Q3 | -- | -- | $0.50 | $0.49 | $0.01 |
07/25/2019 | Q2 | -- | -- | $0.28 | $0.37 | -$0.09 |
04/25/2019 | Q1 | -- | -- | $0.53 | $1.03 | -$0.50 |
02/21/2019 | Q4 | -- | -- | $1.52 | $1.03 | $0.49 |
10/25/2018 | Q3 | -- | -- | $1.12 | $1.13 | -$0.01 |
07/26/2018 | Q2 | -- | -- | $1.37 | $1.47 | -$0.10 |
04/26/2018 | Q1 | -- | -- | $2.08 | $1.78 | $0.30 |
02/22/2018 | Q4 | -- | -- | $1.64 | $1.69 | -$0.05 |
10/26/2017 | Q3 | -- | -- | $1.42 | $1.27 | $0.15 |
07/27/2017 | Q2 | -- | -- | $1.38 | $1.28 | $0.10 |
04/27/2017 | Q1 | -- | -- | -- | $1.38 | -- |
02/23/2017 | Q4 | -- | -- | $1.82 | $1.36 | $0.46 |
10/27/2016 | Q3 | -- | -- | $1.10 | $0.75 | $0.35 |
07/28/2016 | Q2 | -- | -- | $1.22 | $0.67 | $0.55 |
04/28/2016 | Q1 | -- | -- | $1.22 | $0.97 | $0.25 |
02/25/2016 | Q4 | -- | -- | $1.18 | $0.88 | $0.30 |
11/05/2015 | Q3 | -- | -- | $0.56 | $0.32 | $0.24 |
Visteon reported $934M worth of top line sales in its most recent quarter.
Visteon announced earnings per share of $2.36 which represents a beat of analyst forecast a $1.86 per share.
Visteon reported $138M that represents $5.02 per share over the last quarter.
Visteon's earnings are forecast to decrease from $9.82 per share to $8.38 per share next year representing a decrease of -17.55%.
Visteon's next earnings date is July 24, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.